Overview
Drug pricing and valuation consulting addresses the complex economic frameworks that govern how pharmaceuticals are priced, reimbursed, and valued across the healthcare system. MDT Expert Consulting provides access to health economists, pharmacoeconomists, and former payer and manufacturer executives who evaluate pricing strategies, rebate structures, formulary placement decisions, and the economic basis for damages in pharmaceutical disputes involving price-fixing allegations, reimbursement fraud, and commercial contract matters.
Pre-Litigation Support
Before litigation, drug pricing experts help counsel understand the economic and commercial framework underlying the dispute. They analyze pricing benchmarks, reimbursement data, rebate agreements, and formulary economics to assess whether the pricing conduct at issue was consistent with industry norms and applicable legal standards. This early analysis is critical to evaluating exposure in antitrust, False Claims Act, and commercial contract matters.
Litigation Support
In litigation, drug pricing and valuation experts assist in interpreting complex pricing data, evaluating the economic impact of alleged misconduct, and quantifying damages in pharmaceutical disputes. They help counsel frame discovery around pricing models, contract terms, and reimbursement records, and they evaluate the methodologies used by opposing economic experts.
Arbitration Support
In arbitration, drug pricing experts address commercial disputes involving supply agreements, rebate contracts, and formulary placement arrangements. Their ability to translate complex pharmaceutical economics into clear, accessible analysis is particularly valuable in proceedings where arbitrators may not have specialized industry knowledge.